IFP Advisors’s Mateon Therapeutics, Inc. MATN Stock Holding History

IFP Advisors’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-61,196	Closed	-$12K	–	3529
2021 Q2	$12K	Sell	61,196 -1,641	-3%	-$322	﹤0.01%	2162
2021 Q1	$22K	Buy	62,837 +238	+0.4%	+$83	﹤0.01%	1824
2020 Q4	$13K	Buy	62,599 +26,879	+75%	+$5.58K	﹤0.01%	1973
2020 Q3	$6K	Buy	+35,720	New	+$6K	﹤0.01%	2141

IFP Advisors's MATN Position: Q3 2021 in Review

IFP Advisors sold out of Mateon Therapeutics, Inc. (MATN) in Q3 2021, closing a stake of 61,196 shares — an estimated $12K sold.

IFP Advisors first reported a position in MATN in Q3 2020 and held it in 4 quarters. The position peaked at $22K in Q1 2021. 0 funds tracked by Wall St. Rank hold MATN as of Q3 2021.

IFP Advisors reported no remaining Mateon Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
IFP Advisors sold 61,196 Mateon Therapeutics, Inc. shares in Q3 2021, an estimated $12K.
IFP Advisors first reported a position in Mateon Therapeutics, Inc. in Q3 2020 and held it in 4 quarters.
IFP Advisors's Mateon Therapeutics, Inc. position peaked at $22K in Q1 2021.
0 funds tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q3 2021.

Based on IFP Advisors's 13F filing for Q3 2021, filed 6 Oct 2021.